Your browser doesn't support javascript.
loading
Genomic analysis of primary plasma cell leukemia reveals complex structural alterations and high-risk mutational patterns.
Schinke, Carolina; Boyle, Eileen M; Ashby, Cody; Wang, Yan; Lyzogubov, Valeriy; Wardell, Christopher; Qu, Pingping; Hoering, Antje; Deshpande, Shayu; Ryan, Katie; Thanendrarajan, Sharmilan; Mohan, Meera; Yarlagadda, Naveen; Khan, Maliha; Choudhury, Samrat Roy; Zangari, Maurizio; van Rhee, Frits; Davies, Faith; Barlogie, Bart; Morgan, Gareth; Walker, Brian A.
Afiliação
  • Schinke C; Myeloma Center, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA. cdschinke@uams.edu.
  • Boyle EM; Myeloma Center, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Ashby C; Myeloma Center, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Wang Y; Myeloma Center, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Lyzogubov V; Myeloma Center, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Wardell C; Myeloma Center, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Qu P; Cancer Research and Biostatistics, Seattle, WA, USA.
  • Hoering A; Cancer Research and Biostatistics, Seattle, WA, USA.
  • Deshpande S; Myeloma Center, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Ryan K; Myeloma Center, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Thanendrarajan S; Myeloma Center, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Mohan M; Myeloma Center, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Yarlagadda N; Myeloma Center, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Khan M; Myeloma Center, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Choudhury SR; Myeloma Center, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Zangari M; Myeloma Center, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • van Rhee F; Myeloma Center, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Davies F; Myeloma Center, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Barlogie B; Department of Hematology and Medical Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Morgan G; Myeloma Center, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
  • Walker BA; Myeloma Center, Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, AR, USA. bw75@iu.edu.
Blood Cancer J ; 10(6): 70, 2020 06 19.
Article em En | MEDLINE | ID: mdl-32555163

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Plasmocitária / Mutação Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Leucemia Plasmocitária / Mutação Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article